Evidence map›Paper›PMID 32162003›Full record

ArticleEuropean radiology2020

Radiomics for lung adenocarcinoma manifesting as pure ground-glass nodules: invasive prediction.

Yingli Sun, Cheng Li, Liang Jin, Pan Gao, Wei Zhao, Weiling Ma, Mingyu Tan, Weilan Wu, Shaofeng Duan, Yuqing Shan and 1 more

Open access · hybridAbstract read
In one paragraph

Article in European radiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 1 pooled it
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 1 synthesis or guideline pooled it, 141 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Yingli SunDepartment of Radiology, Huadong Hospital Affiliated to Fudan University, Shanghai, 200040, China.
Cheng LiDepartment of Radiology, Huadong Hospital Affiliated to Fudan University, Shanghai, 200040, China.
Liang JinDepartment of Radiology, Huadong Hospital Affiliated to Fudan University, Shanghai, 200040, China.
Pan GaoDepartment of Radiology, Huadong Hospital Affiliated to Fudan University, Shanghai, 200040, China.
Wei ZhaoDepartment of Radiology, Huadong Hospital Affiliated to Fudan University, Shanghai, 200040, China.
Weiling MaDepartment of Radiology, Huadong Hospital Affiliated to Fudan University, Shanghai, 200040, China.
Mingyu TanDepartment of Radiology, Huadong Hospital Affiliated to Fudan University, Shanghai, 200040, China.
Weilan WuDepartment of Radiology, Huadong Hospital Affiliated to Fudan University, Shanghai, 200040, China.
Shaofeng DuanGE Healthcare, Shanghai, 210000, China.
Yuqing ShanDepartment of Radiology, The People's Hospital of Rizhao, Rizhao City, 276800, China.
Ming LiDepartment of Radiology, Huadong Hospital Affiliated to Fudan University, Shanghai, 200040, China. minli77@163.com.
Huadong Hospital · CNFudan University · CNPeople’s Hospital of Rizhao · CNUnited Imaging Healthcare (China) · CN

Funding

National Natural Science Foundation of China 61976238Science and Technology Commission of Shanghai Municipality (CN) 2018ZHYL0103
6 · The paper itself

Abstract

objectivesTo investigate the value of radiomics based on CT imaging in predicting invasive adenocarcinoma manifesting as pure ground-glass nodules (pGGNs).

methodsThis study enrolled 395 pGGNs with histopathology-confirmed benign nodules or adenocarcinoma. A total of 396 radiomic features were extracted from each labeled nodule. A Rad-score was constructed with the least absolute shrinkage and selection operator (LASSO) in the training set. Multivariate logistic regression analysis was conducted to establish the radiographic model and the combined radiographic-radiomics model. The predictive performance was validated by receiver operating characteristic (ROC) curve. Based on the multivariate logistic regression analysis, an individual prediction nomogram was developed and the clinical utility was assessed.

resultsFive radiomic features and four radiographic features were selected for predicting the invasive lesions. The combined radiographic-radiomics model (AUC 0.77; 95% CI, 0.69-0.86) performed better than the radiographic model (AUC 0.71; 95% CI, 0.62-0.81) and Rad-score (AUC 0.72; 95% CI, 0.63-0.81) in the validation set. The clinical utility of the individualized prediction nomogram developed using the Rad-score, margin, spiculation, and size was confirmed in the validation set. The decision curve analysis (DCA) indicated that using a model with Rad-score to predict the invasive lesion would be more beneficial than that without Rad-score and the clinical model.

conclusionsThe proposed radiomics-based nomogram that incorporated the Rad-score, margin, spiculation, and size may be utilized as a noninvasive biomarker for the assessment of invasive prediction in patients with pGGNs. KEY POINTS: • CT-based radiomics analysis helps invasive prediction manifested as pGGNs. • The combined radiographic-radiomics model may be utilized as a noninvasive biomarker for predicting invasive lesion for pGGNs. • Radiomics-based individual nomogram may serve as a vital decision support tool to identify invasive pGGNs, obviating further workup and blind follow-up.

Indexed as

Adenocarcinoma of LungAdultAgedFemaleHumansLogistic ModelsLung NeoplasmsMachine LearningMaleMiddle AgedMultiple Pulmonary NodulesMultivariate AnalysisNeoplasm InvasivenessNomogramsROC CurveTomography, X-Ray ComputedAdenocarcinomaLungNomogramsSolitary pulmonary noduleX-ray computed tomography

Identifiers

PMID32162003
PMCPMC7305264
OpenAlexW3010662565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.